# Sunitinib Before and After Surgery in Treating Patients With Stage IV Kidney Cancer

> **NCT00717587** · PHASE2 · UNKNOWN · sponsor: **Abramson Cancer Center at Penn Medicine** · enrollment: 20 (estimated)

## Conditions studied

- Kidney Cancer

## Interventions

- **DRUG:** motexafin gadolinium
- **DRUG:** sunitinib malate
- **GENETIC:** comparative genomic hybridization
- **GENETIC:** gene expression analysis
- **GENETIC:** mutation analysis
- **GENETIC:** polymorphism analysis
- **OTHER:** immunohistochemistry staining method
- **OTHER:** iodine I-124 girentuximab
- **OTHER:** laboratory biomarker analysis
- **OTHER:** pharmacological study
- **PROCEDURE:** adjuvant therapy
- **PROCEDURE:** neoadjuvant therapy
- **PROCEDURE:** therapeutic conventional surgery

## Key facts

- **NCT ID:** NCT00717587
- **Lead sponsor:** Abramson Cancer Center at Penn Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-06
- **Primary completion:** 2010-07
- **Final completion:** —
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2014-01-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00717587

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00717587, "Sunitinib Before and After Surgery in Treating Patients With Stage IV Kidney Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00717587. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*